Tekamlo FDA Approval History
FDA Approved: Yes (Discontinued) (First approved August 26, 2010)
Brand name: Tekamlo
Generic name: aliskiren and amlodipine
Dosage form: Tablets
Company: Novartis Pharmaceuticals Corporation
Treatment for: High Blood Pressure
Marketing Status: Discontinued
Tekamlo (aliskiren and amlodipine) is a direct renin inhibitor and calcium channel blocker combination indicated for the treatment of high blood pressure.
Development Timeline for Tekamlo
|Aug 27, 2010||Approval Novartis receives FDA approval of Tekamlo, a single-pill combination of aliskiren and amlodipine to treat high blood pressure|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.